Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, and who have finished their main treatment (surgery and chemotherapy).
- People who have been taking a type of cancer maintenance medication called a PARP inhibitor for at least 2 months, and who plan to keep taking it for at least another 7 months.
- People who speak English.
- People who are experiencing a moderate-to-significant level of fatigue, as measured by a short questionnaire (confirm with trial site for exact score required).
- People who are well enough to carry out basic daily activities, with some allowance for those who have some limitations due to illness (confirm with trial site on exact fitness level required).
- People who are willing to use a special wireless pill bottle to track when they take their PARP inhibitor medication.
Who may not be able to join:
- People who have an untreated health condition that existed before they started their PARP inhibitor and that their cancer doctor believes could explain their fatigue.
- People who have a serious untreated mental health condition — such as severe trauma unrelated to cancer or significant risk of self-harm — that their cancer doctor believes would require more intensive support than this trial can offer.
- People who have a condition affecting memory or thinking, such as dementia, that their cancer doctor determines would prevent them from giving informed consent or completing the trial tasks.
- People who are unable to complete the first study questionnaire within one week of agreeing to join the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alexi A Wright, MD, MPH, Dana-Farber Cancer Institute
Phone: 857.215.4936
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Fatigue Interference Score from Baseline to 20 weeks (Arms 1 and 2)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.